Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug–Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization-Reference-Cited by-同舟云学术

Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug–Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization

Published:2022-02 Issue:2 Volume:10 Page:506-516.e6
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Quint Tamara,Dahm Valerie,Ramazanova Dariga,Arnoldner Michael A.,Kurz Harald,Janik Stefan,Brunner Patrick M.,Knerer-Schally Birgit,Weninger Wolfgang,Griss Johannes,Ristl Robin,Schneider Sven,Bangert Christine

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference46 articles.

1. Aspirin-exacerbated respiratory disease (AERD): current understanding of AERD;Taniguchi;Allergol Int,2019

2. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology

3. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)—a EAACI position paper;Kowalski;Allergy,2019

4. Pathogenesis of aspirin-induced reactions in aspirin-exacerbated respiratory disease;Cahill;Immunol Allergy Clin North Am,2016

5. Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis;Higashi;J Allergy Clin Immunol,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab dampens mucosal type 2 response during acetylsalicylic acid challenge in N-ERD patients;2024-06-07

2. Hat die ASS-Desaktivierung in Zeiten von Biologika noch einen Stellenwert bei chronischer Rhinosinusitis mit nasaler Polyposis?;HNO;2024-02-26

3. IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab;Journal of Allergy and Clinical Immunology;2024-02

4. Mast Cells in Aspirin-Exacerbated Respiratory Disease;Current Allergy and Asthma Reports;2024-01-13

5. Management of Aspirin-Exacerbated Respiratory Disease;Otolaryngologic Clinics of North America;2023-10